(54) postulated an inverse correlation between AKT or pAKT and PD-L1 expression in lung adenocarcinomas in line with a poor response of patients with EGFR mutations to PD-1/PD-L1 inhibitors. The gene discussed is AKT1; the disease is lung adenocarcinoma.